Liquid preservation of polymorphonuclear leukocytes: effect of various additives on chemotaxis preservation. 1991

L Verstraeten, and M Marchand-Arvier, and F Schooneman, and C Vigneron
Centre régional de transfusion sanguine de Nancy-Brabois, Vandoeuvre-les-Nancy, France.

Adequate storage of polymorphonuclear leukocytes would allow an easier in vitro study of their structure and their functions, an easier study of polymorphonuclear leukocyte diseases (e.g. chronic granulomatous disease) and an easier use of polymorphonuclear leukocytes as a clinical tool (e.g. for localizing infections). Unfortunately, polymorphonuclear leukocytes are nearly impossible to preserve, even in short-term storage. This study proposes a model for the study of polymorphonuclear leukocyte storage in a synthetic medium: Plasmion. For storage over a period of 24 h, we found that supplementation with each of the following additives: bicarbonate buffer, glucose, adenosine triphosphate (ATP), ascorbic acid, nicotinamide adenine dinucleotide (NADH), nicotinamide adenine dinucleotide phosphate (NADPH), alpha-tocopherol acetate, amikacin and ampicillin, significantly improves (p less than 0.05) one or several functions of the polymorphonuclear leukocytes. When samples were stored for 48 h, we found that the addition of bicarbonate buffer after 24 h significantly improves the maintenance of several functions of polymorphonuclear leukocytes, in particular chemotaxis. Preservation for 96 h was achieved by making additions of supplements on each day of storage, with a chemotaxis maintenance of 83% at 24 h, 59% at 48 h, 46% at 24 h and 20% at 96 h. In conclusion, by using the Plasmion medium, and adding the above-mentioned compounds on each day of storage, chemotaxis can be satisfactorily maintained over 4 days.

UI MeSH Term Description Entries
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D010587 Phagocytosis The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES). Phagocytoses
D010952 Plasma Substitutes Any liquid used to replace blood plasma, usually a saline solution, often with serum albumins, dextrans or other preparations. These substances do not enhance the oxygen- carrying capacity of blood, but merely replace the volume. They are also used to treat dehydration. Blood Expanders,Plasma Volume Expanders,Expanders, Blood,Expanders, Plasma Volume,Substitutes, Plasma,Volume Expanders, Plasma
D001793 Blood Preservation The process by which blood or its components are kept viable outside of the organism from which they are derived (i.e., kept from decay by means of a chemical agent, cooling, or a fluid substitute that mimics the natural state within the organism). Blood Preservations,Preservation, Blood,Preservations, Blood
D002634 Chemotaxis, Leukocyte The movement of leukocytes in response to a chemical concentration gradient or to products formed in an immunologic reaction. Leukotaxis,Leukocyte Chemotaxis
D005780 Gelatin A product formed from skin, white connective tissue, or bone COLLAGEN. It is used as a protein food adjuvant, plasma substitute, hemostatic, suspending agent in pharmaceutical preparations, and in the manufacturing of capsules and suppositories. Gelafusal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations

Related Publications

L Verstraeten, and M Marchand-Arvier, and F Schooneman, and C Vigneron
April 1995, Journal of chemotherapy (Florence, Italy),
L Verstraeten, and M Marchand-Arvier, and F Schooneman, and C Vigneron
June 1978, The Journal of bone and joint surgery. American volume,
L Verstraeten, and M Marchand-Arvier, and F Schooneman, and C Vigneron
September 1985, Biochimica et biophysica acta,
L Verstraeten, and M Marchand-Arvier, and F Schooneman, and C Vigneron
March 1968, Biochemical pharmacology,
L Verstraeten, and M Marchand-Arvier, and F Schooneman, and C Vigneron
May 1978, The Journal of cell biology,
L Verstraeten, and M Marchand-Arvier, and F Schooneman, and C Vigneron
January 1984, Biochemical pharmacology,
L Verstraeten, and M Marchand-Arvier, and F Schooneman, and C Vigneron
January 1980, Blood cells,
L Verstraeten, and M Marchand-Arvier, and F Schooneman, and C Vigneron
June 1989, Journal of pharmacobio-dynamics,
L Verstraeten, and M Marchand-Arvier, and F Schooneman, and C Vigneron
November 2011, Journal of leukocyte biology,
L Verstraeten, and M Marchand-Arvier, and F Schooneman, and C Vigneron
February 1984, Journal of medical microbiology,
Copied contents to your clipboard!